Compare NUVL & SUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NUVL | SUN |
|---|---|---|
| Founded | 2017 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.1B |
| IPO Year | 2021 | N/A |
| Metric | NUVL | SUN |
|---|---|---|
| Price | $104.39 | $53.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $134.29 | $63.75 |
| AVG Volume (30 Days) | ★ 828.0K | 503.7K |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 6.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.93 |
| Revenue | N/A | ★ $21,870,000,000.00 |
| Revenue This Year | N/A | $2.83 |
| Revenue Next Year | N/A | $10.99 |
| P/E Ratio | ★ N/A | $18.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $55.54 | $47.98 |
| 52 Week High | $112.88 | $59.88 |
| Indicator | NUVL | SUN |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 48.17 |
| Support Level | $103.52 | $52.76 |
| Resistance Level | $107.99 | $54.43 |
| Average True Range (ATR) | 3.18 | 1.00 |
| MACD | -0.93 | -0.24 |
| Stochastic Oscillator | 10.43 | 22.28 |
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.
Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states. The operating convenience stores are under the APlus, Stripes, Aloha Island Mart, and Tigermarket brands.